TrialCancer chemotherapy and pharmacology2014

Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).

Rathi N Pillai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.